Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Sandmann S, Unger T
L- and T-type calcium channel blockade - the efficacy of the calcium channel antagonist mibefradil
Journal of Clinical and Basic Cardiology 1999; 2 (2): 187-201

PDF    Summary    Overview   

First Image Fig. 5: Kalziumkanal - Mibefradil Fig. 6: Kalziumkanal - Mibefradil Fig. 7: Kalziumkanal - Mibefradil This Image - Fig. 8A-B: Kalziumkanal - Mibefradil Fig. 9: Kalziumkanal - Mibefradil Fig. 10: Kalziumkanal - Mibefradil Fig. 11: Kalziumkanal - Mibefradil Last Image
Figure/Graphic 8A-B: Kalziumkanal - Mibefradil
Cumulative concentration-response curves for the effects of mibefradil, verapamil, and nifedipine on force of contraction in isolated, electrically driven human left ventricular papillary muscle strips. Original records (A) of isometric force of contraction after application of mibefradil (upper) and nifedipine (lower) and a summary of the results (B) are shown. Ordinate in B, force of contraction in percentage of predrug value. Abscissa in B, concentration of drug (in microM). Number of strips is shown in brackets.
 
Kalziumkanal - Mibefradil
Previous Image Next Image   


Figure/Graphic 8A-B: Kalziumkanal - Mibefradil
Cumulative concentration-response curves for the effects of mibefradil, verapamil, and nifedipine on force of contraction in isolated, electrically driven human left ventricular papillary muscle strips. Original records (A) of isometric force of contraction after application of mibefradil (upper) and nifedipine (lower) and a summary of the results (B) are shown. Ordinate in B, force of contraction in percentage of predrug value. Abscissa in B, concentration of drug (in microM). Number of strips is shown in brackets.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung